- Apadaz https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/208653s000lbl.pdf#page=35 - Brilinta https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/022433s022lbl.pdf#page=25 - Simponi https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2017/125433s020s021lbl.pdf# page=32 - Depakene https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/018723s060,019680s047lbl. pdf#page=97 - Depakote ER https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/018723s060,019680s047lbl. pdf#page=97 - Steglujan https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/209805s001lbl.pdf#page=32
jueves, 15 de marzo de 2018
Drug Safety and Availability > Medication Guides
Drug Safety and Availability > Medication Guides
![U.S. Food and Drug Administration Header](https://blogger.googleusercontent.com/img/proxy/AVvXsEhmNymzf199_DVLtHiWvEg46OWOWnk_RaCwPfFFvl22zQLuukx9iwtkDpSn_u5AEyX41YlAKQqzJHeAYemhXe87qldBtEyCSqzNcgS-twkU_9cxw0avlOf49Lq8HzmTAB6ojGQlJFg5VNicAl4NX5VXxZs4NZvAMJLbo6eBC-2KH1_aIm-cpz-cRxv7gnNrNuiaDJGPANKhgPEe-pxAy2l892CK2JLRDx3oux5PiDsId1DYM219ifdC65Eq4N_gN2ZTXm2lPcdb0gWYoAg4fzk0Fj0154DmcA=s0-d-e1-ft)
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario